Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Astria Therapeutics, Inc. - Common Stock (NQ:ATXS)

12.58 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	12.58
Bid (Size)	12.12 (100)
Ask (Size)	12.75 (200)
Prev. Close	12.58
Today's Range	12.58 - 12.58
52wk Range	5.250 - 13.29
Shares Outstanding	56,434,219
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Astria Stockholders Vote to Approve Acquisition by BioCryst

January 21, 2026

From Astria Therapeutics, Inc.

Via Business Wire

Halper Sadeh LLC Encourages ATXS, GDOT, UBFO Shareholders to Contact the Firm to Discuss Their Rights

December 20, 2025

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Performance

YTD	-2.4%	-2.4%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	-2.9%	-2.9%
1 Year	+117.3%	+117.3%

More News

Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights

November 22, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play ↗

October 14, 2025

Via Stocktwits

Astria Therapeutics Inc (NASDAQ:ATXS) Reports Q3 2025 Earnings Miss, Focus Remains on Pending Acquisition and Pipeline ↗

November 12, 2025

Via Chartmill

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

November 12, 2025

From Astria Therapeutics, Inc.

Via Business Wire

Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart

November 06, 2025

From Astria Therapeutics, Inc.

Via Business Wire

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting

October 31, 2025

From Astria Therapeutics, Inc.

Via Business Wire

HALPER SADEH LLC ENCOURAGES PLYM, HOLX, ATXS, PCH SHAREHOLDERS to Contact the Firm to Discuss Their Rights

October 27, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

October 27, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

October 21, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Unusual volume stocks in Monday's session ↗

October 20, 2025

Via Chartmill

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates RYN, PCH, ATXS on Behalf of Shareholders

October 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Astria Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS

October 17, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders

October 16, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

October 16, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday ↗

October 16, 2025

Via Benzinga

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ATXS and RYN on Behalf of Shareholders

October 15, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings ↗

October 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 14, 2025

Via Benzinga

BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate' ↗

October 14, 2025

Via Benzinga

Which stocks are gapping on Tuesday? ↗

October 14, 2025

Via Chartmill

Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday ↗

October 14, 2025

Via Benzinga

Which stocks are moving before the opening bell on Tuesday? ↗

October 14, 2025

Via Chartmill

ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders

October 14, 2025

From Halper Sadeh LLC

Via Business Wire

Frequently Asked Questions

Is Astria Therapeutics, Inc. - Common Stock publicly traded?

Yes, Astria Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Astria Therapeutics, Inc. - Common Stock trade on?

Astria Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Astria Therapeutics, Inc. - Common Stock?

The ticker symbol for Astria Therapeutics, Inc. - Common Stock is ATXS on the Nasdaq Stock Market

What is the current price of Astria Therapeutics, Inc. - Common Stock?

The current price of Astria Therapeutics, Inc. - Common Stock is 12.58

When was Astria Therapeutics, Inc. - Common Stock last traded?

The last trade of Astria Therapeutics, Inc. - Common Stock was at 01/22/26 04:00 PM ET

What is the market capitalization of Astria Therapeutics, Inc. - Common Stock?

The market capitalization of Astria Therapeutics, Inc. - Common Stock is 709.94M

How many shares of Astria Therapeutics, Inc. - Common Stock are outstanding?

Astria Therapeutics, Inc. - Common Stock has 710M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.